SCHEMBL17445625

SCHEMBL17445625

COc1ccc(Oc2cc(NCCC(F)(F)F)c3ncc(-c4ccc(C)c(C)c4)n3n2)c(F)c1F

nearest known ligand 0.75

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ TTK P33981 18/20 0.75
▸ FYN P06241 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19336838 0.90 TTK (0.75) TTK
SCHEMBL19336837 0.89 TTK (0.67) TTKFYN
Bay-1217389 SCHEMBL15555839 0.86 TTK (1.00) TTK
Bay-1217389 SCHEMBL30381937 0.86 TTK (1.00) TTK
SCHEMBL17445623 0.86 TTK (0.62) TTK
SCHEMBL19336811 0.83 TTK (0.59) TTK
SCHEMBL19336843 0.83 TTK (0.61) TTK
SCHEMBL17445626 0.81 TTK (0.78) TTKFYN
SCHEMBL17571044 0.81 TTK (0.91) TTK
SCHEMBL17559993 0.80 TTK (0.90) TTK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9512130-B2 Substituted imidazopyridazines BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2016-12-06 — — US disclosed
US-20160016959-A1 SUBSTITUTED IMIDAZOPYRIDAZINES BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2016-01-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160016959-A1 SUBSTITUTED IMIDAZOPYRIDAZINES VEGFA, PGF, VHL TTK 2301/4885FYN 1587/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback